FIELD: medicine.
SUBSTANCE: claimed group of inventions relates to medicine, namely to oncology, and can be applied for treatment of neoplasm, as well as for producing medication for it treatment. For this purpose virus of Newcastle disease in combination with gluoropyrimidine and camptothecin compound during one or more cycles in total quantity, effective for subject treatment.
EFFECT: application of claimed inventions results in stable regression of tumour due to synergetic anti-tumour effect from application of all three agents.
30 cl, 4 dwg, 7 tbl, 5 ex
| Title | Year | Author | Number |
|---|---|---|---|
| VIRUS AND CAMPTOTHECIN BASED TREATMENT OF MALIGNANT GROWTH | 2005 |
|
RU2408387C2 |
| TREATMENT OF STOMACH CANCER USING COMBINATION TYPES OF THERAPY CONTAINING LIPOSOMAL IRINOTECAN, OXALIPLATIN, 5-FLUOROURACIL (AND LEUCOVORIN) | 2017 |
|
RU2761953C2 |
| METHOD FOR INTRODUCING THERAPEUTIC VIRUSES | 2003 |
|
RU2314830C2 |
| ANTICANCER COMPOSITIONS CONTAINING AGENT INHIBITING VEGF AND 5FU OR ONE OF ITS DERIVATIVES | 2005 |
|
RU2384344C2 |
| METHODS OF TREATING PANCREAS CANCER USING COMBINATION THERAPY INCLUDING LIPOSOMAL IRINOTECAN | 2013 |
|
RU2808427C2 |
| METHODS FOR TREATING PANCREATIC CANCER USING COMBINATION THERAPY COMPRISING LIPOSOMAL IRINOTECAN | 2013 |
|
RU2663450C2 |
| APPLICATION OF ALLOPURINOL FOR TREATING PALMOPLANTAR ERYTHRODYSESTHESIA | 2007 |
|
RU2438673C2 |
| ADMINISTRATION OF MULTIPLE BOLUSES [6R]-MTHF IN CHEMOTHERAPY BASED ON 5-FLUOROURACIL | 2018 |
|
RU2762596C2 |
| METHODS FOR INCREASING LEVEL OF 2'-DEOXYURIDINE (DURD) IN PLASMA AND INHIBITING THYMIDYLATE SYNTHASE | 2018 |
|
RU2775781C2 |
| THERAPEUTIC COMBINATIONS CONTAINING INHIBITOR OF POLY(ADP-RIBOSE)POLYMERASE | 2005 |
|
RU2361592C2 |
